311 related articles for article (PubMed ID: 25708579)
21. Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.
Rouprêt M; Hupertan V; Traxer O; Loison G; Chartier-Kastler E; Conort P; Bitker MO; Gattegno B; Richard F; Cussenot O
Urology; 2006 Jun; 67(6):1181-7. PubMed ID: 16765178
[TBL] [Abstract][Full Text] [Related]
22. [Instillation therapies for urothelial carcinoma of the upper urinary tract].
Bosshard P; Thalmann GN; Roth B
Urologe A; 2019 Jan; 58(1):25-29. PubMed ID: 30649582
[TBL] [Abstract][Full Text] [Related]
23. Endoscopic treatment of upper tract transitional cell carcinoma.
Soderdahl DW; Fabrizio MD; Rahman NU; Jarrett TW; Bagley DH
Urol Oncol; 2005; 23(2):114-22. PubMed ID: 15869996
[TBL] [Abstract][Full Text] [Related]
24. Organ-sparing procedures in GU cancer: part 3-organ-sparing procedures in urothelial cancer of upper tract, bladder and urethra.
Khalil MI; Alliston JT; Bauer-Erickson JJ; Davis R; Bissada NK; Kamel MH
Int Urol Nephrol; 2019 Nov; 51(11):1903-1911. PubMed ID: 31352580
[TBL] [Abstract][Full Text] [Related]
25. Management of patients with upper urinary tract transitional cell carcinoma.
Raman JD; Scherr DS
Nat Clin Pract Urol; 2007 Aug; 4(8):432-43. PubMed ID: 17673914
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
[TBL] [Abstract][Full Text] [Related]
28. Nephron-sparing management of upper tract urothelial carcinoma.
Farrow JM; Kern SQ; Gryzinski GM; Sundaram CP
Investig Clin Urol; 2021 Jul; 62(4):389-398. PubMed ID: 34190434
[TBL] [Abstract][Full Text] [Related]
29. Laser therapy for upper urinary tract transitional cell carcinoma: indications and management.
Bader MJ; Sroka R; Gratzke C; Seitz M; Weidlich P; Staehler M; Becker A; Stief CG; Reich O
Eur Urol; 2009 Jul; 56(1):65-71. PubMed ID: 19108945
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of instillations with chemotherapy or immunotherapy following endoscopic resection for upper tract urothelial carcinoma.
Bachir BG; Kassouf W
Expert Rev Anticancer Ther; 2012 Jan; 12(1):63-75. PubMed ID: 22149433
[TBL] [Abstract][Full Text] [Related]
31. Safety and feasibility of early single-dose mitomycin C bladder instillation after robot-assisted radical nephroureterectomy.
Gulamhusein A; Silva P; Cullen D; Tran M; Mumtaz F; Patki P; Barod R; Bex A
BJU Int; 2020 Dec; 126(6):739-744. PubMed ID: 32638490
[TBL] [Abstract][Full Text] [Related]
32. Percutaneous management of renal pelvic urothelial tumors: long-term followup.
Goel MC; Mahendra V; Roberts JG
J Urol; 2003 Mar; 169(3):925-9; discussion 929-30. PubMed ID: 12576814
[TBL] [Abstract][Full Text] [Related]
33. Intracavitary therapies for upper tract urothelial carcinoma.
Knoedler JJ; Raman JD
Expert Rev Clin Pharmacol; 2018 May; 11(5):487-493. PubMed ID: 29634361
[TBL] [Abstract][Full Text] [Related]
34. Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours.
Bin X; Roy OP; Ghiraldi E; Manglik N; Liang T; Vira M; Kavoussi LR
BJU Int; 2012 Dec; 110(11 Pt B):E514-9. PubMed ID: 22578024
[TBL] [Abstract][Full Text] [Related]
35. Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys.
Chen GL; Bagley DH
J Urol; 2000 Oct; 164(4):1173-6. PubMed ID: 10992360
[TBL] [Abstract][Full Text] [Related]
36. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
Xylinas E; Rink M; Cha EK; Clozel T; Lee RK; Fajkovic H; Comploj E; Novara G; Margulis V; Raman JD; Lotan Y; Kassouf W; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Zigeuner R; Pycha A; Scherr DS; Seitz C; Walton T; Trinh QD; Karakiewicz PI; Matin S; Montorsi F; Zerbib M; Shariat SF;
Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
[TBL] [Abstract][Full Text] [Related]
37. Elective segmental ureterectomy for transitional cell carcinoma of the ureter: long-term follow-up in a series of 73 patients.
Simonato A; Varca V; Gregori A; Benelli A; Ennas M; Lissiani A; Gacci M; De Stefani S; Rosso M; Benvenuto S; Siena G; Belgrano E; Gaboardi F; Carini M; Bianchi G; Carmignani G
BJU Int; 2012 Dec; 110(11 Pt B):E744-9. PubMed ID: 23134540
[TBL] [Abstract][Full Text] [Related]
38. Ureteroscopic management of upper tract urothelial carcinoma (UTUC) in patients with Lynch Syndrome (hereditary nonpolyposis colorectal cancer syndrome).
Hubosky SG; Boman BM; Charles S; Bibbo M; Bagley DH
BJU Int; 2013 Oct; 112(6):813-9. PubMed ID: 23452166
[TBL] [Abstract][Full Text] [Related]
39. Thulium Laser Treatment of Upper Urinary Tract Carcinoma: A Multi-Institutional Analysis of Surgical and Oncological Outcomes.
Musi G; Mistretta FA; Marenghi C; Russo A; Catellani M; Nazzani S; Conti A; Luzzago S; Ferro M; Matei DV; Carmignani L; de Cobelli O
J Endourol; 2018 Mar; 32(3):257-263. PubMed ID: 29357686
[TBL] [Abstract][Full Text] [Related]
40. Oncologic results of nephron sparing endoscopic approach for upper tract low grade transitional cell carcinoma in comparison to nephroureterectomy - a case control study.
Hoffman A; Yossepowitch O; Erlich Y; Holland R; Lifshitz D
BMC Urol; 2014 Dec; 14():97. PubMed ID: 25468319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
